• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

接受手术联合调强放射治疗(IMRT)、三维适形放射治疗或传统放射治疗的头颈癌患者的预后因素。

Prognostic factors in head-and-neck cancer patients treated with surgery followed by intensity-modulated radiotherapy (IMRT), 3D-conformal radiotherapy, or conventional radiotherapy.

作者信息

Rades Dirk, Fehlauer Fabian, Wroblesky Junes, Albers Dirk, Schild Steven E, Schmidt Rainer

机构信息

Department of Radiation Oncology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.

出版信息

Oral Oncol. 2007 Jul;43(6):535-43. doi: 10.1016/j.oraloncology.2006.05.006. Epub 2006 Sep 26.

DOI:10.1016/j.oraloncology.2006.05.006
PMID:17005437
Abstract

In 148 head-and-neck cancer patients treated with surgery plus radiotherapy (RT), IMRT, 3D-conformal RT, and conventional RT and 10 potential prognostic factors were evaluated for overall survival (OS), metastasis-free survival (MFS), and loco-regional control (LC). On univariate analysis, ECOG performance status, T-stage, AJCC-stage, extent of resection, and pre-RT hemoglobin level (>or=12 g/dl better than <12 g/dl) were significantly associated with treatment outcome, whereas RT technique had no significant impact. On multivariate analysis, performance status maintained significance for OS (P=0.019), AJCC-stage for LC (P=0.034), extent of resection for OS (P=0.045) and MFS (P=0.021), pre-RT hemoglobin for MFS (P<0.001). IMRT was associated with less xerostomia than conformal RT and conventional RT (17% versus 63% and 73%, P=0.037). Otherwise, acute and late toxicity was similar. Outcome was significantly associated with performance status, tumor stage, extent of resection, and pre-RT hemoglobin. The three radiation techniques provided similar disease control. IMRT was effective in significantly reducing xerostomia.

摘要

在148例接受手术加放疗(RT)、调强放疗(IMRT)、三维适形放疗(3D - conformal RT)和传统放疗的头颈癌患者中,对10个潜在的预后因素进行了总生存期(OS)、无转移生存期(MFS)和局部区域控制(LC)的评估。单因素分析显示,美国东部肿瘤协作组(ECOG)体能状态、T分期、美国癌症联合委员会(AJCC)分期、切除范围以及放疗前血红蛋白水平(≥12 g/dl优于<12 g/dl)与治疗结果显著相关,而放疗技术无显著影响。多因素分析显示,体能状态对OS仍具有显著意义(P = 0.019),AJCC分期对LC具有显著意义(P = 0.034),切除范围对OS(P = 0.045)和MFS(P = 0.021)具有显著意义,放疗前血红蛋白对MFS具有显著意义(P<0.001)。与适形放疗和传统放疗相比,IMRT导致的口干症较少(17% 对比63%和73%,P = 0.037)。此外,急性和晚期毒性相似。结果与体能状态、肿瘤分期、切除范围和放疗前血红蛋白显著相关。三种放疗技术提供了相似的疾病控制效果。IMRT在显著减少口干症方面有效。

相似文献

1
Prognostic factors in head-and-neck cancer patients treated with surgery followed by intensity-modulated radiotherapy (IMRT), 3D-conformal radiotherapy, or conventional radiotherapy.接受手术联合调强放射治疗(IMRT)、三维适形放射治疗或传统放射治疗的头颈癌患者的预后因素。
Oral Oncol. 2007 Jul;43(6):535-43. doi: 10.1016/j.oraloncology.2006.05.006. Epub 2006 Sep 26.
2
Evaluation of prognostic factors and two radiation techniques in patients treated with surgery followed by radio(chemo)therapy or definitive radio(chemo)therapy for locally advanced head-and-neck cancer.局部晚期头颈癌患者接受手术联合放(化)疗或根治性放(化)疗后,对预后因素和两种放疗技术的评估
Strahlenther Onkol. 2008 Apr;184(4):198-205. doi: 10.1007/s00066-008-1825-3.
3
Radio(chemo)therapy plus resection versus radio(chemo)therapy alone for the treatment of stage III esophageal cancer.放射(化学)治疗联合手术切除与单纯放射(化学)治疗用于治疗Ⅲ期食管癌
Strahlenther Onkol. 2007 Jan;183(1):10-6. doi: 10.1007/s00066-007-1583-7.
4
The prognostic value of anaemia at different treatment times in patients with locally advanced head and neck cancer treated with surgery and postoperative radiotherapy.局部晚期头颈癌患者接受手术及术后放疗时不同治疗时间贫血的预后价值
Clin Oncol (R Coll Radiol). 2007 May;19(4):228-33. doi: 10.1016/j.clon.2007.02.009. Epub 2007 Mar 12.
5
Brachytherapy versus surgery in carcinoma of tonsillar fossa and/or soft palate: late adverse sequelae and performance status: can we be more selective and obtain better tissue sparing?扁桃体窝和/或软腭癌近距离放射治疗与手术治疗的比较:晚期不良后遗症及功能状态:我们能否更具选择性并实现更好的组织保留?
Int J Radiat Oncol Biol Phys. 2004 Jul 1;59(3):713-24. doi: 10.1016/j.ijrobp.2003.11.032.
6
Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacy.调强放疗用于原发灶不明的头颈部癌:毒性及初步疗效
Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1100-7. doi: 10.1016/j.ijrobp.2007.07.2351. Epub 2007 Nov 5.
7
Radiation treatment interruptions greater than one week and low hemoglobin levels (12 g/dL) are predictors of local regional failure after definitive concurrent chemotherapy and intensity-modulated radiation therapy for squamous cell carcinoma of the head and neck.对于头颈部鳞状细胞癌,在进行根治性同步化疗和调强放射治疗后,放疗中断超过一周以及血红蛋白水平低(<12 g/dL)是局部区域复发的预测因素。
Am J Clin Oncol. 2009 Dec;32(6):587-91. doi: 10.1097/COC.0b013e3181967dd0.
8
Efficacy and toxicity of reirradiation using intensity-modulated radiotherapy for recurrent or second primary head and neck cancer.调强放疗再治疗复发性或第二原发头颈部癌症的疗效和毒性。
Cancer. 2010 Oct 15;116(20):4761-8. doi: 10.1002/cncr.25305.
9
Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program.调强放射治疗可降低放射诱导的发病率并改善健康相关生活质量:一项使用标准化随访方案的非随机前瞻性研究结果
Int J Radiat Oncol Biol Phys. 2009 May 1;74(1):1-8. doi: 10.1016/j.ijrobp.2008.07.059. Epub 2008 Dec 26.
10
Predictive factors of local-regional recurrences following parotid sparing intensity modulated or 3D conformal radiotherapy for head and neck cancer.头颈部癌保留腮腺调强放疗或三维适形放疗后局部区域复发的预测因素。
Radiother Oncol. 2005 Oct;77(1):32-8. doi: 10.1016/j.radonc.2005.07.008. Epub 2005 Sep 8.

引用本文的文献

1
Evaluation and Comparison of the Dose Received by the Mandible, Maxilla, and Teeth in Two Methods of Three-dimensional Conformal Radiation Therapy and Helical Tomotherapy.三维适形放射治疗和螺旋断层放射治疗两种方法中下颌骨、上颌骨及牙齿所接受剂量的评估与比较
J Med Signals Sens. 2024 Sep 2;14:26. doi: 10.4103/jmss.jmss_42_23. eCollection 2024.
2
Quality of life following treatment with intra-arterial cisplatin with concurrent radiation and erlotinib for locally advanced head and neck cancer.局部晚期头颈部癌经动脉内顺铂联合放疗和厄洛替尼治疗后的生活质量。
Support Care Cancer. 2024 Jan 9;32(2):93. doi: 10.1007/s00520-023-08286-1.
3
Impact of a mobile application (reminder app) on acute toxicity during radiotherapy of head-and-neck cancer - results of a randomized phase III trial (RAREST-02).
移动应用程序(提醒应用程序)对头颈部癌症放射治疗期间急性毒性的影响 - 一项随机 III 期试验(RAREST-02)的结果。
BMC Cancer. 2022 Sep 17;22(1):989. doi: 10.1186/s12885-022-10088-3.
4
Prognostic Factors for Complete Recovery From Xerostomia After Radiotherapy of Head-and-Neck Cancers.头颈部癌症放疗后口干完全缓解的预后因素。
In Vivo. 2022 Jul-Aug;36(4):1795-1800. doi: 10.21873/invivo.12894.
5
Clinical characteristics and prognosis of elderly nasopharyngeal carcinoma patients receiving intensity-modulated radiotherapy.老年鼻咽癌调强放疗患者的临床特征和预后。
Eur Arch Otorhinolaryngol. 2021 Jul;278(7):2549-2557. doi: 10.1007/s00405-020-06399-5. Epub 2020 Oct 6.
6
Radiotherapy-related skin toxicity (RAREST-02): A randomized trial testing the effect of a mobile application reminding head-and-neck cancer patients to perform skin care (reminder app) on radiation dermatitis.放疗相关性皮肤毒性(RAREST-02):一项随机试验,旨在测试提醒头颈部癌症患者进行皮肤护理的移动应用(提醒应用程序)对放射性皮炎的影响。
Trials. 2020 May 25;21(1):424. doi: 10.1186/s13063-020-04307-0.
7
Radiotherapy related skin toxicity (RAREST-01): Mepitel® film versus standard care in patients with locally advanced head-and-neck cancer.放疗相关皮肤毒性(RAREST-01):局部晚期头颈部癌患者的 Mepitel®薄膜与标准护理的比较。
BMC Cancer. 2018 Feb 17;18(1):197. doi: 10.1186/s12885-018-4119-x.
8
Prolonged radiation time and low nadir hemoglobin during postoperative concurrent chemoradiotherapy are both poor prognostic factors with synergistic effect on locally advanced head and neck cancer patients.术后同期放化疗期间的辐射时间延长和最低血红蛋白水平低都是局部晚期头颈部癌症患者的不良预后因素,具有协同作用。
Onco Targets Ther. 2015 Jan 28;8:251-8. doi: 10.2147/OTT.S70204. eCollection 2015.
9
Prognostic Value of Metabolic Tumor Volume Measured by (18)F-FDG PET/CT in Locally Advanced Head and Neck Squamous Cell Carcinomas Treated by Surgery.通过(18)F-FDG PET/CT测量的代谢肿瘤体积在接受手术治疗的局部晚期头颈部鳞状细胞癌中的预后价值
Nucl Med Mol Imaging. 2011 Mar;45(1):43-51. doi: 10.1007/s13139-010-0063-7. Epub 2010 Nov 16.
10
The treatment outcome and radiation-induced toxicity for patients with head and neck carcinoma in the IMRT era: a systematic review with dosimetric and clinical parameters.调强放疗时代头颈部癌患者的治疗结果和放射性毒性:基于剂量学和临床参数的系统评价。
Biomed Res Int. 2013;2013:401261. doi: 10.1155/2013/401261. Epub 2013 Oct 22.